Navigation Links
Pre-Diabetes/Impaired Glucose Tolerance Global Clinical Trials Review, H2, 2013
Date:11/5/2013

London (PRWEB) November 05, 2013

Summary

GlobalData's clinical trial report, “Pre-Diabetes/Impaired Glucose Tolerance Global Clinical Trials Review, H2, 2013" provides data on the Pre-Diabetes/Impaired Glucose Tolerance clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Pre-Diabetes/Impaired Glucose Tolerance. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Pre-Diabetes/Impaired Glucose Tolerance. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

-Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
-Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
-Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

-Understand the dynamics of a particular indication in a condensed manner
-Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
-Obtain discontinued trial listing for trials across the globe
-Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 7
Introduction 8
Pre-Diabetes/Impaired Glucose Tolerance 8
Report Guidance 8
Clinical Trials by Region 9
Clinical Trials by Country 10
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
Top Five Countries Contributing to Clinical Trials in Europe 13
Top Countries Contributing to Clinical Trials in North America 14
Top Countries Contributing to Clinical Trials in Middle East and Africa 15
Top Five Countries Contributing to Clinical Trials in Central and South America 16
Clinical Trials by BRIC Nations 17
Clinical Trials by G7 Nations 18
Clinical Trials in G7 Nations by Trial Status 19
Clinical Trials by E7 Nations 20
Clinical Trials in E7 Nations by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Unaccomplished Trials of Pre-Diabetes/Impaired Glucose Tolerance 25
Subjects Recruited Over a Period of Time 29
Prominent Sponsors 30
Top Companies Participating in Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials 32
Prominent Drug Comparison 34
Clinical Trial Profiles 35
Clinical Trial Overview of Top Companies 35
Novartis AG 35
Clinical Trial Overview of Novartis AG 35
Genfit SA 36
Clinical Trial Overview of Genfit SA 36
Sanofi 37
Clinical Trial Overview of Sanofi 37
Novo Nordisk A/S 38
Clinical Trial Overview of Novo Nordisk A/S 38
Merck & Co., Inc. 39
Clinical Trial Overview of Merck & Co., Inc. 39
Generex Biotechnology Corporation 40
Clinical Trial Overview of Generex Biotechnology Corporation 40
Limerick BioPharma, Inc. 41
Clinical Trial Overview of Limerick BioPharma, Inc. 41
NuMe Health LLC 42
Clinical Trial Overview of NuMe Health LLC 42
KineMed, Inc. 43
Clinical Trial Overview of KineMed, Inc. 43
Arete Therapeutics Inc. 44
Clinical Trial Overview of Arete Therapeutics Inc. 44
New Chapter, Inc. 45
Clinical Trial Overview of New Chapter, Inc. 45
Cadila Pharmaceuticals Ltd. 46
Clinical Trial Overview of Cadila Pharmaceuticals Ltd. 46
Resverlogix Corp. 47
Clinical Trial Overview of Resverlogix Corp. 47
Bayer AG 48
Clinical Trial Overview of Bayer AG 48
UnitedHealth Group Incorporated 49
Clinical Trial Overview of UnitedHealth Group Incorporated 49
Marico Limited 50
Clinical Trial Overview of Marico Limited 50
Forest Laboratories, Inc. 51
Clinical Trial Overview of Forest Laboratories, Inc. 51
Takeda Pharmaceutical Company Limited 52
Clinical Trial Overview of Takeda Pharmaceutical Company Limited 52
Bioneer Corporation 53
Clinical Trial Overview of Bioneer Corporation 53
Daiichi Sankyo Company, Limited 54
Clinical Trial Overview of Daiichi Sankyo Company, Limited 54
Clinical Trial Overview of Top Institutes / Government 55
The National Institute of Diabetes and Digestive and Kidney Diseases 55
Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases 55
U.S. Department of Veterans Affairs 56
Clinical Trial Overview of U.S. Department of Veterans Affairs 56
Yale University 57
Clinical Trial Overview of Yale University 57
University of Toronto 58
Clinical Trial Overview of University of Toronto 58
University of Eastern Finland 59
Clinical Trial Overview of University of Eastern Finland 59
Maastricht University Medical Center 60
Clinical Trial Overview of Maastricht University Medical Center 60
University of Leipzig 61
Clinical Trial Overview of University of Leipzig 61
National Taiwan University Hospital 62
Clinical Trial Overview of National Taiwan University Hospital 62
Eunice Kennedy Shriver National Institute of Child Health and Human Development 63
Clinical Trial Overview of Eunice Kennedy Shriver National Institute of Child Health and Human Development 63
Pennington Biomedical Research Foundation 64
Clinical Trial Overview of Pennington Biomedical Research Foundation 64
Mayo Clinic 65
Clinical Trial Overview of Mayo Clinic 65
University of Minnesota 66
Clinical Trial Overview of University of Minnesota 66
Duke University 67
Clinical Trial Overview of Duke University 67
Stanford University 68
Clinical Trial Overview of Stanford University 68
Beth Israel Deaconess Medical Center 69
Clinical Trial Overview of Beth Israel Deaconess Medical Center 69
Chinese University of Hong Kong 70
Clinical Trial Overview of Chinese University of Hong Kong 70
Emory University 71
Clinical Trial Overview of Emory University 71
Karolinska Institutet 72
Clinical Trial Overview of Karolinska Institutet 72
Mount Sinai School of Medicine 73
Clinical Trial Overview of Mount Sinai School of Medicine 73
The University of Chicago 74
Clinical Trial Overview of The University of Chicago 74
Five Key Clinical Profiles 75
Appendix 104
Abbreviations 104
Definitions 104
Research Methodology 105
Secondary Research 105
About GlobalData 106
Contact Us 106
Disclaimer 106
Source 107

List of Tables

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Market, Global, Clinical Trials by Zone, 2013* 9
Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 10
Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 11
Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2013* 12
Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials, Europe, Top Five Countries, 2013* 13
Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials, North America, Top Countries, 2013* 14
Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2013* 15
Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2013* 16
Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials, BRIC Countries, 2013* 17
Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials, G7 Countries, 2013* 18
Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 19
Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials, E7 Countries, 2013* 20
Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 21
Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Market, Global, Clinical Trials by Phase, 2013* 22
Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 23
Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 24
Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Market, Global, Suspended Clinical Trials, 2013* 25
Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Market, Global, Withdrawn Clinical Trials, 2013* 26
Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Market, Global, Terminated Clinical Trials, 2013* 27
Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 29
Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 31
Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 33
Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 34
Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2013* 35
Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Genfit SA, 2013* 36
Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2013* 37
Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Novo Nordisk A/S, 2013* 38
Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2013* 39
Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Generex Biotechnology Corporation, 2013* 40
Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Limerick BioPharma, Inc., 2013* 41
Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by NuMe Health LLC, 2013* 42
Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by KineMed, Inc., 2013* 43
Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Arete Therapeutics Inc., 2013* 44
Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by New Chapter, Inc., 2013* 45
Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Cadila Pharmaceuticals Ltd., 2013* 46
Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Resverlogix Corp., 2013* 47
Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2013* 48
Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by UnitedHealth Group Incorporated, 2013* 49
Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Marico Limited, 2013* 50
Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Forest Laboratories, Inc., 2013* 51
Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2013* 52
Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Bioneer Corporation, 2013* 53
Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2013* 54
Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2013* 55
Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Veterans Affairs, 2013* 56
Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Yale University, 2013* 57
Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Toronto, 2013* 58
Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Eastern Finland, 2013* 59
Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Maastricht University Medical Center, 2013* 60
Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Leipzig, 2013* 61
Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2013* 62
Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Eunice Kennedy Shriver National Institute of Child Health and Human Development, 2013* 63
Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Pennington Biomedical Research Foundation, 2013* 64
Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2013* 65
Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Minnesota, 2013* 66
Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2013* 67
Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2013* 68
Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Beth Israel Deaconess Medical Center, 2013* 69
Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Chinese University of Hong Kong, 2013* 70
Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Emory University, 2013* 71
Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Karolinska Institutet, 2013* 72
Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Mount Sinai School of Medicine, 2013* 73
Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Chicago, 2013* 74

List of Figures

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 9
Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 10
Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 11
Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2013* 12
Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013* 13
Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials, North America, Top Countries (%), 2013* 14
Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2013* 15
Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2013* 16
Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials, BRIC Countries (%), 2013* 17
Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials, G7 Countries (%), 2013* 18
Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 19
Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials, E7 Countries (%), 2013* 20
Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 21
Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 22
Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 23
Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 24
Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 29
Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 30
Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 32
Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 34
GlobalData Methodology 105

Read the full report:

Pre-Diabetes/Impaired Glucose Tolerance Global Clinical Trials Review, H2, 2013

http://www.reportbuyer.com/pharma_healthcare/drug_discovery/pre_diabetes_impaired_glucose_tolerance_global_clinical_trials_review_h2_2013.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Discovery_and_Development

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: query@reportbuyer.com
Tel: +44 208 816 85 48
Website: http://www.reportbuyer.com/

Read the full story at http://www.prweb.com/releases/2013/11/prweb11303486.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved


Related medicine news :

1. Heart failure patients with diabetes may benefit from higher glucose levels
2. Skp2 activates cancer-promoting, glucose-processing Akt
3. Aggressively controlling glucose levels may not reduce kidney failure in Type 2 diabetes
4. Glucose deprivation activates feedback loop that kills cancer cells, UCLA study shows
5. QuickMedical® Offers The WaveSense Blood Glucose Monitoring System
6. Sensor detects glucose in saliva and tears for diabetes testing
7. Measuring glucose without needle pricks
8. JDRF announces winners of first phase of Agnes Varis Glucose-Responsive Insulin Challenge
9. Dietary glucose affects the levels of a powerful oncogene in mice
10. Metformin improves blood glucose levels and BMI in very obese children
11. New guidelines for standardizing glucose reporting and optimizing clinical decision making in diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... ... 10 Best Water is excited to announce a new monthly ... topped the list as a result of their commitment to offering clients creative, customized, ... 5100, a top notch water company that specializes in providing the public with refreshing ...
(Date:2/10/2016)... ... February 10, 2016 , ... United Benefit Advisors (UBA), ... latest addition to its growing list of Partner Firms. S.S. Nesbitt is ... Orlando to Huntsville and in between. , Harnessing the experience and insights of ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... change in their patients. Research shows that the Goal Attainment Scale (GAS) captures ... overcome this challenge and learn more about the Goal Attainment Scale, Education Resources ...
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... ... revolutionary, biocompatible columns and accessories. These PEEK-lined stainless steel (PLS) columns combine the ... a solution that ensures the integrity of biological samples while operating at ultra-high ...
(Date:2/10/2016)... DC (PRWEB) , ... February 10, 2016 , ... Anxiety ... level since the start of Medicare Part D a decade ago, according to ... comments from older adults on how they are coping with rapidly rising costs. ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)...  Visage Imaging Inc. ("Visage"), a wholly owned ... that the American College of Radiology (ACR) and ... Visage 7 Enterprise Imaging Platform as the new ... SIMulation (SIM). SIM is the assessment component of ... multi-faceted and fully-integrated online assessment, education and remediation ...
(Date:2/10/2016)... Mast Therapeutics, Inc. (NYSE MKT: ... sickle cell disease and heart failure, today announced the ... at a price to the public of $0.275 per ... Company,s common stock and one warrant to purchase one ... price of $0.42 per share. The warrants are exercisable ...
(Date:2/10/2016)... New York , February 10, 2016 ... Growth, Trends and Forecast 2015 - 2023 ", reveals that ... rather slow growth from 2015 to 2023 owing to patent ... a meager CAGR of 1.30% during the forecast period, the ... to US$38.9 bn in 2023. --> Antibacterial Drugs ...
Breaking Medicine Technology: